Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Science 37 Holdings, Inc. (SNCE : NSDQ)

• Company Description    Science 37 Inc. provides operating system for agile clinical trials. Science 37 Inc., formerly known as LifeSci Acquisition II Corp., is based in LOS ANGELES. Number of Employees: 600

• Price / Volume Information    Yesterday's Closing Price: $3.00 Daily Weekly Monthly 20 Day Moving Average: 318,271 shares Shares Outstanding: 116.00 (millions) Market Capitalization: $347.99 (millions) Beta: 1.40 52 Week High: $15.10 52 Week Low: $2.79 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -33.48% -27.11% 12 Week -61.04% -57.73% Year To Date -75.94% -71.39%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 800 PARK OFFICES DRIVE SUITE 3606 - NORTH CAROLINA,NC 27709 USA ph: 984-377-3737 fax: - investors@science37.com http://www.science37.com

• General Corporate Information    Officers David Coman - Chief Executive Officer and Director Robert Faulkner - Chairman Mike Zaranek - Chief Financial Officer Adam Goulburn - Director Adam Goulburn - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 808644108 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: - Share - Related Items Shares Outstanding: 116.00 Most Recent Split Date: (:1) Beta: 1.40 Market Capitalization: $347.99 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.22 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.45 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.99 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 13.79% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -8.29% ROE 03/31/22 - -95.04 12/31/21 - -146.10 09/30/21 - -1,223.14 ROA 03/31/22 - -42.91 12/31/21 - -36.79 09/30/21 - -25.59 Current Ratio 03/31/22 - 6.40 12/31/21 - 6.64 09/30/21 - 0.40 Quick Ratio 03/31/22 - 6.40 12/31/21 - 6.64 09/30/21 - 0.40 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - -87.38 12/31/21 - -158.28 09/30/21 - -9.77 Book Value 03/31/22 - 1.50 12/31/21 - 1.06 09/30/21 - -0.20 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - - Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - -

Powered by Zacks Investment Research ©